CLASS II Device recall · Reported 15 Mar 2017 · FDA Enforcement Report

Haemophilus Test Medium (Agar) in A) recalled by Remel

Remel is recalling Remel, Haemophilus Test Medium (Agar) in A), distributed nationwide in the US. The recall was initiated on 9 Feb 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesA) Lot: 978596, 2017-01-30; B) Lot: 978948, 2017/01/30
Quantity recalledRO4033 - 163, R01503 - 50.

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1400-2017
FDA event ID
76445
Recalling firm
Remel, Lenexa, KS
Classification
Class II
Status
Terminated
Recall initiated
9 Feb 2017
FDA classified
3 Mar 2017
Reported
15 Mar 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

9 Feb 2017Recall initiated by company
3 Mar 2017Classified by FDA+22 days
15 Mar 2017Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Test organisms exhibit poor growth when grown using the test agar. The poor growth can give users incorrect AST zones when performing susceptibility tests.

Product as listed by the FDA

Remel, Haemophilus Test Medium (Agar) in A) 100 mm REF R01503, and B) 150 mm plates REF R04033,

Where it was distributed

USA ( nationwide ) Distribution including Puerto Rico and to the states of : AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, RI, SD, TN, TX, VA, VT, WA, WI, WV and WY.

Nationwide AlaskaAlabamaArkansasArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaFloridaGeorgiaHawaiiIowaIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMaine

Questions about this recall

Is Haemophilus Test Medium (Agar) in A) recalled?

Yes. Remel recalled Haemophilus Test Medium (Agar) in A) on 9 Feb 2017. The recall is Class II and its status is Terminated. Recall number Z-1400-2017.

Why was it recalled?

Test organisms exhibit poor growth when grown using the test agar. The poor growth can give users incorrect AST zones when performing susceptibility tests.

Which lots are affected?

A) Lot: 978596, 2017-01-30; B) Lot: 978948, 2017/01/30

Where was it sold?

USA ( nationwide ) Distribution including Puerto Rico and to the states of : AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, RI, SD, TN, TX, VA, VT, WA, WI, WV and WY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Remel

All 86
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIGC Agar Base R04030 recalled by RemelRemelOtherNationwide
DeviceCLASS IIYeastone Broth, 10/BOX YY3462 recalled by RemelRemelMoldNationwide
DeviceCLASS IICampy CVA Medium, R01272 recalled by RemelRemelOtherNationwide
DeviceCLASS IICamhb W/lhb, Manual, 10/box Ycp112-10 Brucella Broth, 10/box Yt3450 recalledRemelOtherNationwide
DeviceCLASS IIBlood/EMB, Levine, Product Number R02041 recalled by RemelRemelListeriaNationwide

Other Other Medical Devices recalls

All 13,778